These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26491951)

  • 21. Low-Intensity Shockwave for Treatment of Vestibulodynia: A Randomized Controlled Therapy Trial.
    Gruenwald I; Gutzeit O; Petruseva A; Gartman I; Lowenstein L
    J Sex Med; 2021 Feb; 18(2):347-352. PubMed ID: 33419704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Open-label study evaluating outpatient urethral sphincter injections of onabotulinumtoxinA to treat women with urinary retention due to a primary disorder of sphincter relaxation (Fowler's syndrome).
    Panicker JN; Seth JH; Khan S; Gonzales G; Haslam C; Kessler TM; Fowler CJ
    BJU Int; 2016 May; 117(5):809-13. PubMed ID: 26435296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidisciplinary Treatment for Provoked Vestibulodynia: Treatment Trajectories, Predictors, and Moderators of Sexual Distress and Pain.
    Smith KB; Sadownik LA; Dargie E; Albert AYK; Brotto LA
    Clin J Pain; 2019 Apr; 35(4):335-344. PubMed ID: 30614827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin (OnabotulinumtoxinA) in the male non-neurogenic overactive bladder: clinical and quality of life outcomes.
    Habashy D; Losco G; Tse V; Collins R; Chan L
    BJU Int; 2015 Oct; 116 Suppl 3():61-5. PubMed ID: 26176660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vestibular hyaluronic acid injection in provoked vestibulodynia patients and its effect on pain and sexual function: A preliminary report.
    Eserdag S; Akdag Özkok B; Süphan Ersahin S; Zeynep Yilmaz E
    Eur J Obstet Gynecol Reprod Biol; 2023 Jan; 280():64-67. PubMed ID: 36410243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. OnabotulinumtoxinA for Treatment of Moderate to Severe Crow's Feet Lines: A Review.
    Carruthers A; Bruce S; Cox SE; Kane MA; Lee E; Gallagher CJ
    Aesthet Surg J; 2016 May; 36(5):591-7. PubMed ID: 26979457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An academic debate: OnabotulinumtoxinA for chronic migraine: PREEMPT-derived vs "customized" dosing/injection paradigm.
    Green MW; Rothrock JF
    Toxicon; 2018 Jun; 147():116-119. PubMed ID: 29596847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin for chronic migraine: Clinical trials and technical aspects.
    Tassorelli C; Sances G; Avenali M; De Icco R; Martinelli D; Bitetto V; Nappi G; Sandrini G
    Toxicon; 2018 Jun; 147():111-115. PubMed ID: 28877509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exclusive manual perineal rehabilitation with lidocaine 2% gel in the treatment of provoked vestibulodynia: results from a single-arm interventional study.
    Close A; Culha MG; Albert V; Valancogne G
    Int J Impot Res; 2023 Mar; 35(2):157-163. PubMed ID: 35228685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness analysis of onabotulinumtoxinA (BOTOX(®)) for the management of urinary incontinence in adults with neurogenic detrusor overactivity: a UK perspective.
    Hamid R; Loveman C; Millen J; Globe D; Corbell C; Colayco D; Stanisic S; Gultyaev D
    Pharmacoeconomics; 2015 Apr; 33(4):381-93. PubMed ID: 25526842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of botulinum toxin injection in the treatment of de novo OAB symptoms following midurethral sling surgery.
    Miotla P; Futyma K; Cartwright R; Bogusiewicz M; Skorupska K; Markut-Miotla E; Rechberger T
    Int Urogynecol J; 2016 Mar; 27(3):393-8. PubMed ID: 26364180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pruritus associated with onabotulinumtoxinA treatment of neuromuscular pain.
    Ho D; Jagdeo J
    J Drugs Dermatol; 2015 Feb; 14(2):199-200. PubMed ID: 25689816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Topical Therapy for Provoked Vestibulodynia: Improvement of Psychological and Sexual Well-Being.
    De Seta F; Ianniello P; Carlucci S; Nappi L; Sorrentino F; Stabile G
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine.
    Lipton RB; Varon SF; Grosberg B; McAllister PJ; Freitag F; Aurora SK; Dodick DW; Silberstein SD; Diener HC; DeGryse RE; Nolan ME; Turkel CC
    Neurology; 2011 Oct; 77(15):1465-72. PubMed ID: 21956721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of botulinum toxin injection for neurogenic detrusor overactivity: Switch of toxin versus second injection of the same toxin.
    Peyronnet B; Castel-Lacanal E; Manunta A; Roumiguié M; Marque P; Rischmann P; Gamé X
    Int J Urol; 2015 Dec; 22(12):1160-5. PubMed ID: 26391575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin B in the treatment of craniofacial hyperhidrosis.
    Karlqvist M; Rosell K; Rystedt A; Hymnelius K; Swartling C
    J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1313-7. PubMed ID: 24118460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Palmar Hyperhidrosis With Needle Injection Versus Low-Pressure Needle-Free Jet Injection of OnabotulinumtoxinA: An Open-Label Prospective Study.
    Vadeboncoeur S; Richer V; Nantel-Battista M; Benohanian A
    Dermatol Surg; 2017 Feb; 43(2):264-269. PubMed ID: 27893541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of onabotulinumtoxinA in post-traumatic oromandibular dystonia.
    Pedemonte C; Pérez Gutiérrez H; González E; Vargas I; Lazo D
    J Oral Maxillofac Surg; 2015 Jan; 73(1):152-7. PubMed ID: 25315313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgery for localized, provoked vestibulodynia: a long-term follow-up study.
    Bohm-Starke N; Rylander E
    J Reprod Med; 2008 Feb; 53(2):83-9. PubMed ID: 18357798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after stroke.
    Dunne JW; Gracies JM; Hayes M; Zeman B; Singer BJ;
    Clin Rehabil; 2012 Sep; 26(9):787-97. PubMed ID: 22308557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.